NEXT Life Sciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NEXT Life Sciences, Inc. - overview
Location
San Luis Obispo, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, NEXT Life Sciences, Inc. , a. k. a.
NEXT Life Sciences is developing a procedure to bring a non-hormonal, long-lasting, and reversible male contraception solution. In January 2025, NEXT Life Sciences, Inc. raised USD 200,000 in grant funding from returning investor Male Contraceptive Initiative. As of June 2023, L.
R. Fox is the CEO of the company. The company provides Plan A™, which is a reversible birth control for men. The Plan A™ treatment is comparable to a no-scalpel vasectomy, with the exception that the hydrogel serves as a flexible filter to stop the passage of sperm, preventing pregnancy rather than irreversibly severing the vas deferens.
The company plans to use its proceeds from Jan 2025 funding to continue to develop its product, called Plan A.
Current Investors
StartUp Health, Particular Ventures, The Family
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.nextlifesciences.org/
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.